







Atlas Genet Cytogenet Oncol Haematol. 2014; 18(4) 278 
Atlas of Genetics and Cytogenetics 
in Oncology and Haematology 
INIST-CNRS 
 




Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, 
France (JLH) 
 
Published in Atlas Database: September 2013 
Online updated version : http://AtlasGeneticsOncology.org/Anomalies/t0208p15q24ID2138.html 
DOI: 10.4267/2042/53540 
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. 
© 2014 Atlas of Genetics and Cytogenetics in Oncology and Haematology 
 
Abstract 
Review on t(2;8)(p15;q24) BCL11A/MYC, with 
data on clinics, and the genes implicated. 
Clinics and pathology 
Disease 
Diffuse large B-cell lymphoma (DLBCL) 
Epidemiology 
There was one female patient, and a male patient 
aged 81 years (Aamot et al., 2007; Bertrand et al., 
2007). 
Prognosis 




A t(14;18)(q32;q21) was present in both cases. One 
case also presented with +5, +7, +12, and a marker 
chromosome. 
Genes involved and 
proteins 
Note 
In the case described by Bertrand et al., 2007, 






BCL11A is a Krüppel zinc-finger transcription  
factor, which has been shown to be essential for 
pre-B-cell development, thymocyte maturation, and 
globin switching, expressed in haematopoietic and 
neural tissues. BCL11A controls FLT3 and IL7R 
expression in early hematopoietic progenitors (Wu 





DNA binding protein. Binds DNA as a heterodimer 
with MAX. Involved in various cellular processes 
including cell growth, proliferation, cell adhesion, 
apoptosis, angiogenesis, and stem cell behaviour 
modulation. 
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